
ARMP
Healthcare · Biotechnology · $143.9M market cap
$3.87+0.15 (+4.0%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +10.5% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Time not confirmed | -0.57 | -0.24 | +57.9% |
| Aug 12, 2026 | After the close | -0.48 | -0.27 | +43.8% |
| May 13, 2026 | After the close | -0.38 | -3.16 | -731.6% |
| Mar 19, 2026 | Time not confirmed | -0.19 | -0.51 | -169.1% |
| Nov 12, 2025 | After the close | -0.42 | -0.33 | +21.4% |
| Aug 12, 2025 | After the close | -0.39 | -0.29 | +25.6% |
| May 14, 2025 | After the close | -0.38 | -0.20 | +47.4% |
| Mar 19, 2025 | Before the open | -0.35 | -0.23 | +33.8% |
| Nov 13, 2024 | After the close | -0.28 | -0.15 | +46.4% |
| Aug 13, 2024 | After the close | -0.36 | -0.40 | -11.1% |
| May 7, 2024 | After the close | -0.31 | -0.33 | -6.5% |
| Mar 21, 2024 | After the close | -0.35 | -0.55 | -57.1% |
| Nov 14, 2023 | After the close | -0.31 |
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; and AP-PA03 for Pseudomonas…
| -0.32 |
| -3.2% |
| Aug 14, 2023 | Before the open | -0.37 | -0.27 | +27.0% |
| May 11, 2023 | After the close | -0.32 | -0.31 | +3.1% |
| Mar 16, 2023 | After the close | -0.28 | -0.29 | -3.6% |
| Nov 9, 2022 | After the close | -0.28 | -0.24 | +14.3% |
| Aug 11, 2022 | After the close | -0.23 | -0.26 | -13.0% |
| May 12, 2022 | After the close | -0.21 | -0.30 | -42.9% |
| Mar 17, 2022 | After the close | -0.28 | -0.23 | +17.9% |
| Nov 10, 2021 | After the close | -0.26 | -0.25 | +3.8% |
| Aug 12, 2021 | After the close | -0.26 | -0.25 | +3.8% |
| May 13, 2021 | After the close | -0.32 | -0.27 | +15.6% |
| Mar 18, 2021 | After the close | -0.29 | -0.36 | -24.1% |
| Nov 12, 2020 | After the close | -0.25 | -0.31 | -24.0% |
| Aug 13, 2020 | After the close | -0.35 | -0.26 | +25.7% |
| May 14, 2020 | After the close | -0.31 | -0.49 | -58.1% |
| Mar 19, 2020 | After the close | -0.72 | -0.48 | +33.3% |
| Nov 12, 2019 | After the close | -0.45 | -0.73 | -62.2% |
| Aug 14, 2019 | After the close | -0.36 | -0.56 | -55.6% |
| May 6, 2019 | After the close | -1.54 | -1.54 | 0.0% |
| Mar 25, 2019 | Before the open | -0.98 | -2.10 | -114.3% |
| Nov 8, 2018 | After the close | -1.40 | -1.40 | 0.0% |
| Aug 9, 2018 | Before the open | -2.80 | -2.66 | +5.0% |
| May 15, 2018 | After the close | -2.66 | -3.36 | -26.3% |
| Mar 14, 2018 | After the close | -5.04 | -3.50 | +30.6% |